300
Participants
Start Date
May 1, 2022
Primary Completion Date
June 30, 2025
Study Completion Date
December 31, 2025
magnetic resonance
biparametric MRI with protocol including anatomical T2 sequence and diffusion-weighted images (DWI), according to the standards
serum PSA examination
testing of prostate-specific antigen (PSA) in serum
Biopsy
"Men with a positive MR test are planned for a targeted MRI/US fusion and systematic prostate biopsy.~Men with a positive blood marker (either PSA, PSAD, or PHI) are planned for a systematic 12 core biopsy. Positive test results are PSA ≥ 3, integrated marker PSAD ≥ 0.15, and PHI ≥ 35."
RECRUITING
Masaryk Memorial Cancer Institute, Brno
Masaryk University
OTHER
Masaryk Memorial Cancer Institute
OTHER